Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays

Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01760-18. doi: 10.1128/AAC.01760-18. Print 2019 Jan.

Abstract

The determination of antibiotic potency against bacterial strains by assessment of their minimum inhibitory concentration normally uses a standardized broth microdilution assay procedure developed more than 50 years ago. However, certain antibiotics require modified assay conditions in order to observe optimal activity. For example, daptomycin requires medium supplemented with Ca2+, and the lipoglycopeptides dalbavancin and oritavancin require Tween 80 to be added to the growth medium to prevent the depletion of free drug via adsorption to the plastic microplate. In this report, we examine systematically the effects of several different plate types on microdilution broth MIC values for a set of antibiotics against Gram-positive and Gram-negative bacteria, both in medium alone and in medium supplemented with the commonly used additives Tween 80, lysed horse blood, and 50% human serum. We observed very significant differences in measured MICs (up to 100-fold) for some lipophilic antibiotics, such as the Gram-positive lipoglycopeptide dalbavancin and the Gram-negative lipopeptide polymyxins, and found that nonspecific binding plates can replace the need for surfactant additives. Microtiter plate types and any additives should be specified when reporting broth dilution MIC values, as results can vary dramatically for some classes of antibiotics.

Keywords: MIC; additive effects; broth microdilution assay; microtiter plate effects.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglycosides / chemistry
  • Aminoglycosides / pharmacology
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Calcium / pharmacology
  • Ciprofloxacin / chemistry
  • Ciprofloxacin / pharmacology
  • Colistin / chemistry
  • Colistin / pharmacology
  • Culture Media / chemistry*
  • Culture Media / pharmacology
  • Depsipeptides / chemistry
  • Depsipeptides / pharmacology
  • Escherichia coli / drug effects*
  • Escherichia coli / growth & development
  • Escherichia coli / metabolism
  • Factor Analysis, Statistical
  • Lipoglycopeptides / chemistry
  • Lipoglycopeptides / pharmacology
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Methicillin-Resistant Staphylococcus aureus / metabolism
  • Microbial Sensitivity Tests / instrumentation*
  • Oxacillin / chemistry
  • Oxacillin / pharmacology
  • Penicillin G / chemistry
  • Penicillin G / pharmacology
  • Plastics / chemistry
  • Polymyxin B / chemistry
  • Polymyxin B / pharmacology
  • Polysorbates / pharmacology
  • Rifampin / chemistry
  • Rifampin / pharmacology
  • Teicoplanin / analogs & derivatives
  • Teicoplanin / chemistry
  • Teicoplanin / pharmacology
  • Trimethoprim / chemistry
  • Trimethoprim / pharmacology
  • Vancomycin / chemistry
  • Vancomycin / pharmacology

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Culture Media
  • Depsipeptides
  • Lipoglycopeptides
  • Plastics
  • Polysorbates
  • ramoplanin
  • Ciprofloxacin
  • Teicoplanin
  • Vancomycin
  • dalbavancin
  • Trimethoprim
  • Polymyxin B
  • oritavancin
  • Penicillin G
  • Calcium
  • Oxacillin
  • Rifampin
  • telavancin
  • Colistin